MAM
Tag Media announces results of ‘What’s Your Cause?’ contest
MUMBAI: The Tag Media In-store Television Network in India had invited ad agencies, design firms, and students to submit Public Service Announcements (PSAs) for any cause that they strongly support.
The winning ads will be running on the Tag Media Network from today, 10 January 2007 for a month. To view the ads, one can walk into a Spencers outlet. The creative teams involved in the creation of the top three Public Service Announcements will be interviewed and broadcast on the network as well.
The Tag Media Network is India’s first National In-store television network. It claims to have a current reach of over five million viewers through their tie-up with National Supermarket chains Spencers, Foodworld and Fabmall.
The results for the What’s Your Cause contest are as follows:
1) Polio:
Creative Team: N. Selva Kumar, Charudatta B. Chothe
Agency: Seagull Advertising, Pune.
2) Lets Talk about AIDS:
Director:Mr. Abhinay Deo
C/o Ramesh Deo Productaions (P) Ltd
Agency: O&M, Mumbai
3) Smoke
Agency and Team: Devraj Tripathi,
O&M, Mumbai.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
